biotech
FDA Approves Atripla, Once Daily Single Tablet AIDS Drug
Filed in archive Drugs, Vaccines and Therapeutics by ruth on July 14, 2006
FDA Approves Atripla, Once Daily Single Tablet AIDS Drug
The US Food and Drug Administration has approved of the new once-a-day, three-in-one AIDS pill. The drug, called Atripla, was jointly developed by Bristol-Myers Squibb Co and Gilead, Inc, and combines the powers of the commonly prescribed AIDS drugs Sustiva, Viread and Emtriva in one pill, The drug inhibits the Reverse transcriptase, an enzyme HIV needs to replicate.

Certainly not a real breakthrough, but might mean more compliance from AIDS patients. According to the manufacturers, Atripla will cost $1,150.88 for a 30-day supply. No price has been set for developing countries. A similar three-in-one AIDS pill produced by India-based Aurobindo Pharma has also been previously approved. However, this version, which is not sold in the US, contains generic versions of older HIV drugs.

More details from Reuters and from the press releases from Gilead and BMS.

Permalink: FDA Approves Atripla, Once Daily Single Tablet AIDS Drug
Tags: AIDS  HIV  aids  biotech  drug  aids+drug  approves+atripla  single+tablet 
Trackback: http://publish.creative-weblogging.com/publish/mt-tb.pl/29269
img Addthis img Ask img Blinklist img del.icio.us img Digg img Fark img Facebook img Google img Lycos img Ma.gnolia Add this page to Mister Wong Mr Wong img Netscape img Netvousz img Newsvine img Reddit img StumbleUpon img Slashdot img Tailrank img Technorati img Wink img Yahoo

Vote for FDA Approves Atripla, Once Daily Single Tablet AIDS Drug:

  • Currently 6.00/10
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
Rating: 6.00 out of 6 vote(s) cast.
 
Subscribe
Share It
Popular posts from our other blogs:
RSSrss
See all blog subscribe options
Google google
What is RSS?
Yahoo! yahoo
Addthis Subscribe using any feed reader!
Bloglines Bloglines
Newsletter

TwitterFollow us on Twitter!